Institute events

On 8th and 9th December 2017, the Telethon enthralled the public throughout France. Thanks to the Telethon, Genethon developped 8 gene therapie medicines. They are now being tested on patients affected by rare muscle, blood, vision and immune deficiency conditions. The France Televisions networks join AFM-Telethon in expressing their thanks. Thanks to Zazie, to our … [Read more]

Dr. Karim Wahbi, a cardiologist in the Cardiology Department at the Cochin Hospital and the Institute of Myology, led a study in which medical data from nearly 1,300 myotonic dystrophy type 1 (DM1) patients were analysed over 10 years. This allowed to develop and validate a clinical tool useful for healthcare professionals. Myotonic dystrophy type … [Read more]

AveXis, Inc. and Genethon today announced they have entered into an exclusive, worldwide license agreement for in vivo gene therapy delivery of AAV9 vector into the central nervous system (CNS) for the treatment of spinal muscular atrophy (SMA). AveXis, Inc. and Genethon today announced they have entered into an exclusive, worldwide license agreement for in … [Read more]

Bruno Cadot, a researcher in Marc Bitoun’s team at the Myology Centre for Research, has successfully acquired a new confocal microscope for the institute. Eighteen months elapsed between the first applications for funding and installation. Since its inauguration last month, researchers and clinicians have been lining up to use it.   What happened during those … [Read more]

Pre-clinical development of gene editing – therapeutic strategies for neglected mutations Monday February 19th 2018 – 12:00
 Matteo Bovolenta (Genethon, France) Host : Vincent Mouly Institute of Myology auditorium Hôpital de la Pitié-Salpêtrière Building Babinski Entrance 82 bd Vincent Auriol metro Chevaleret

Welcome to the 65th issue of our newsletter!   The Telethon 2017 ended on a counter of more than 75 million euros. A falling number that finds its major explanation in the attention naturally paid to the funeral of Johnny Hallyday, an extremely popular French singer. Thank you to all those who contributed and participated. … [Read more]

In Italpharmaco trial (Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With DMD), first three patients have been screened last days (January 15th, 22nd and 26th, 2018), that is they are included in the selection part of the study. Thereafter, if these patients are eligible, they will be randomized to placebo … [Read more]

Marianne Perreau-Saussine, General Secretary of the Institute of Myology, highlights the main achievements of the institute during 2017 and outlines the perspectives for 2018. What were the main achievements of the Institute of Myology in 2017? Amongst all of our achievements, and for the organisation of research, I would say the arrival of Bertrand Fontaine, … [Read more]

A large consortium led by the University of Tübingen, the Radboud university medical center Nijmegen and the University of Leicester and including in France Eurordis, Orphanet, two major research institutes (Centre de Recherche en Myologie and Institut du Cerveau et de la Moelle épinière) and the Dijon University Hospital, has acquired a € 15 million … [Read more]

Stéphane Vassilopoulos works in the “Physiopathology & Therapy of Autosomal Dominant Centronuclear Myopathy” laboratory within the team led by Marc Bitoun, at the institute’s Myology Centre for Research. He and his group* are interested in muscle-cell membrane proteins, particularly, clathrin and its implication in myopathies. What is the link between autosomal dominant centronuclear myopathy and … [Read more]